APR 1204
OCULAR SURFACE DISEASES

APR 1204 is under development as a non-antibiotic ophthalmic medical device product for conditions such as bacterial conjunctivitis, blepharitis, bacterial keratitis and endophthalmitis. The major advantage of APR-1204 is that, as it will not lead to resistance for commonly associated microbial agents.

TEHCLO® TECHNOLOGY

Tehclo™ is the globally patented nanotechnology platform applied to the production of unique hypochlorous acid solutions that ensures the most consistent quality for best-in-class clinical outcomes.

The nanotechnology applied drives electrolysis using a current several times stronger than other standard electrolysis process, minimizing chloride requirements and producing acid oxidizing solution with >95% hypochlorous acid (HClO) purity and 0% hypochlorite (OCl^-) as well as the lowest pH range (2.5-3.0) and high ORP (>1100 mv).